The Effect of Algae Oil Supplements on Functional Immune Response and Bioavailability of Lipids in Blood, a Pilot Study

NCT07086573 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2025-07-25

No results posted yet for this study

Summary

In this explorative study we will investigate whether two sustainable oil supplements yield equivalent results to fish oil supplements in terms of postprandial immune response, among elderly adults, after standardization of the quantity of DHA among the oils. Results on the bioavailability of DHA from different oil supplements will help determine whether differences in DHA bioavailability lead to differences in immune function. Additionally, we will investigate postprandial inflammatory markers. The outcomes of this exploratorive study will provide insight into the variation between individuals and potential effect sizes, and will aim to conduct more targeted follow-up studies on the effects of algae oils on immune function.

Conditions

  • Functional Immune Response
  • Postprandial Bioavailability DHA
  • Fatty Acid Metabolism

Interventions

DIETARY_SUPPLEMENT

Algae oil 1

DHA Origins 550-Y oil (Fermentalg)

DIETARY_SUPPLEMENT

Algae oil 2

Oleo H-02 (Microalgas)

DIETARY_SUPPLEMENT

Fish oil (control)

Tuna oil

Sponsors & Collaborators

  • Nutricia Research

    collaborator INDUSTRY
  • Fermentalg

    collaborator UNKNOWN
  • Microalgas Oleas de México, S.A. de C.V.

    collaborator UNKNOWN
  • Utrecht University

    collaborator OTHER
  • Maartje van den Belt

    lead OTHER

Principal Investigators

  • Maartje van den Belt, MSc · Wageningen Food and Biobased Research

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-09-22
Primary Completion
2025-11-14
Completion
2025-11-14

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07086573 on ClinicalTrials.gov